Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms

Aim. A clinical observation to highlight the importance of detailed examination in patients with functional gastrointestinal symptoms.

Key points. A 28-yo female patient was admitted with complains of left ileal pain, abdominal distention and up to 4-day stool delay. The complaints had long been interpreted as clinical manifestations of irritable bowel syndrome. No significant abnormalities were revealed in outpatient check-up (general and biochemical blood panels, stool test, abdominal ultrasound, oesophagogastroduodenoscopy). Colonoscopy was performed on admission, with diagnosis of rectal adenocarcinoma. The patient had a prompt surgical intervention, repeated courses of polychemotherapy and is currently followed by an oncologist and coloproctologist. No relapse signs have been reported.

Conclusion. Patients with the complaints satisfying the Rome Criteria Revision IV for functional gastrointestinal diseases should have a thorough examination as per recommendations of the Russian Gastroenterological Association and Russian Association of Coloproctologists.

1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C A Cancer J Clin. 2018;68:394–424. DOI: 10.3322/caac.21492

2. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. Malignant neoplasms in Russia in 2019 (incidence and mortality). М.: P.A. Hertsen Moscow Oncology Research Centre — Branch of NMRRC, Ministry of Health of Russia. 2020.

3. Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73. DOI: 10.1002/cncr.24760

4. Seigel R., Naishadham D., Jemal A. Cancer statistics, 2013. A Cancer J Clin. 2013;63:11–30. DOI: 10.3322/caac.21166

5. Murphy C.C., Sandler R.S., Sanoff H.K., Yang Y.C., Lund J.L., Baron J.A. Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol. 2017;15:903–9.e6. DOI: 10.1016/j.cgh.2016.08.037

6. Siegel R.L., Fedewa S.A., Anderson W.F., Miller K.D., Ma J., Rosenberg P.S., et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst 2017;109(8):djw322. DOI: 10.1093/jnci/djw322

7. Sawicki T., Ruszkowska M., Danielewicz A., Niedźwiedzka E., Arłukowicz T., Przybyłowicz K.E. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). 2021;13(9):2025. DOI: 10.3390/cancers13092025

8. Lacy B.E., Mearin F., Chang L., Chey W.D., Lembo A.J., Simren M., et al. Bowel disorders. Gastroenterology 2016;150(6):1393–407. DOI: 10.1053/j.gastro.2016.02.031

9. Ivashkin V.T., Poluektova Y.A., Reykhart D.V., Shifrin O.S., Beniashvili A.G., Lyashenko O.S., et al. Efficacy of drugs most commonly prescribed at functional gastrointestinal diseases (functional dyspepsia syndrome and irritable bowel syndrome) observational study results. Rus J Gastroenterol Hepatol Coloproctol. 2016;26(4):14–23 (In Russ.). DOI: 10.22416/1382-4376-2016-26-4-14-23

10. Patel P., Bercik P., Morgan D.G., Bolino C., PintosSanchez M.I., Moayyedi P., et al. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol. 2015;50(7):816–23. DOI: 10.3109/00365521.2015.1007079

11. Gu H.X., Zhang Y.L., Zhi F.C., Jiang B., Huang Y. Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case-control study. Int J Colorectal Dis. 2011;26(7):935–40. DOI: 10.1007/s00384-011-1163-2

12. Paudel M.S., Mandal A.K., Shrestha B.,Poudyal N.S., Kc S., Chaudhary S., et al. Prevalence of organic colonic lesions by colonoscopy in patients fulfilling ROME IV criteria of irritable bowel syndrome. JNMA J Nepal Med Assoc. 2018;56(209):487–92.

13. Hsiao C.W., Huang W.Y., Ke T.W., Muo C.H., Chen W.T., Sung F.C., et al. Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study. Eur J Intern Med. 2014;25(1):82– 6. DOI: 10.1016/j.ejim.2013.11.005

14. García Rodríguez L.A., Ruigómez A., Wallander M.A., Johansson S., Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 2000;35(3):306–11. DOI: 10.1080/003655200750024191

15. Nørgaard M., Farkas D.K., Pedersen L., Erichsen R., de la Cour Z.D., Gregersen H. Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer. 2011;104(7):1202–6. DOI: 10.1038/bjc.2011.65

16. Sheptulin A.A., Jahaya N.L., Sedova A.V. Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer? Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(2):76–80 (In Russ.). DOI: 10.22416/1382-4376-2019-29-2-76-80

17. Ivashkin V.T., Shelygin Yu.A., Baranskaya Y.K., Belousova Y.A., Beniashvili A.G., Vasilyev S.V., et al. Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(5):76–93 (In Russ.). DOI: 10.22416/1382-4376-2017-27-5-76-93

18. Mork M.E., You Y.N., Ying J., Bannon S.A., Lynch P.M., Rodriguez-Bigas M.A., et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J Clin Oncol. 2015;33(31):3544–9. DOI: 10.1200/JCO.2015.61.4503

19. Stoffel E.M., Koeppe E., Everett J., Ulintz P., Kiel M., Osborne J., et al. Germline genetic features of young individuals with colorectal cancer. Gastroentero logy. 2018;154(4):897– 905.e1. DOI: 10.1053/j.gastro.2017.11.004

20. Pearlman R., Frankel W.L., Swanson B., Zhao W., Yilmaz A., Miller K., et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3(4):464–71. DOI: 10.1001/jamaoncol.2016.5194

21. Stoffel E.M., Murphy C.C. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology. 2020;158(2):341– 53. DOI: 10.1053/j.gastro.2019.07.055

22. You Y.N., Lee L.D., Deschner B.W., Shibata D. Colorectal cancer in the adolescent and young adult population. JCO Oncol Pract. 2020;16(1):19–27. DOI: 10.1200/JOP.19.00153